podcast Archives - AudioMedica.com

Tagged: podcast

2
- in Cardiovascular
- — 30 Apr, 2008
Bivalirudin For Angioplasty: Expensive Heparin?
Tony Gershlick
Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the
…
Read more
0
- in London School of Hygiene & Tropical Medicine
- — 29 Apr, 2008
Tropical Health Research: London Scientist Honored

Brian Greenwood
Brian Greenwood, London School of Hygiene and Tropical Medicine
Brian Greenwood has won the Hideyo Noguchi Africa Prize for his numerous achievements in tropical disease research. He talked with Derek Thorne about his work, including the pivotal
…
Read more
0
- in Oncology
- — 26 Apr, 2008
Audio Journal of Oncology Volume 16 Number 9
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam
Angel Rodriguez
In this edition:
1. Lapatinib: Targets Breast Cancer Stem Cells?
Angel Rodriguez, Baylor College, Houston…
Read more
4
- in Oncology
- — 25 Feb, 2008
Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon

Kenneth Anderson
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
KENNETH ANDERSON, Dana-Farber Cancer Institute, Boston
Multiple myeloma may soon be considered a chronic disease with cure on the horizon, thanks to an array of novel
…
Read more
0
- in Oncology
- — 15 Feb, 2008
Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

David Cunningham
REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
DAVID CUNNINGHAM, Royal Marsden Hospital, London
The oral agent capeticabine is just as effective as fluorouracil for treating patients whose metastatic colorectal cancer
…
Read more
$Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone$ 0
- in Oncology
- — 1 Feb, 2008
Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone

Cora Sternberg
REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
CORA STERNBERG, San Camillo and Forlanini Hospital, Rome
Satraplatin could provide a new option for patients with hormone refractory prostate cancer, by giving
…
Read more
0
- in News
- — 27 Jan, 2008
Liver Cancer: Risk Groups for Screening

Eugene Schiff
REFERENCE: General Session IV
EUGENE SCHIFF, University of Miami
Screening for Hepatitits C and B, and subsequent screening for cancer, can save millions of lives from hepatocellular carcinoma. Eugene Schiff told the Gastrointestinal Cancers Conference in Orlando which
…
Read more
0
- in Oncology
- — 27 Jan, 2008
Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer

Charles Hsu
CHARLES HSU, Johns Hopkins University, Baltimore
Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a dtudy reported to the conference in Orlando. Charles Hsu told Peter Goodwin
…
Read more
0
- in General Medicine
- — 11 Jan, 2008
Meta-Analysis Proves Statins Help Patients With Diabetes

Colin Baigent
REFERENCE: Lancet 371:117 January 11, 2008
COLIN BAIGENT, Oxford University
Statins were found to cut cardiovascular event rates by a fifth among patients with both Type I and Type II diabetes in a meta-analysis of 18 000
…
Read more
0
- in News
- — 8 Jan, 2008
Early Breast Cancer Chemotherapy: Long Term Findings

Richard Peto
REFERENCE: Lancet 371:29-40; January 5, 2008
RICHARD PETO, Oxford University
The prospect of cutting breast cancer mortality in half throughout the world is held out by Richard Peto of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He
…
Read more
0
- in Oncology
- — 15 Dec, 2007
ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up

Jack Cuzick
JACK CUZICK, Wolfson Institute of Preventive Medicine, London
New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued superiority of the aromatase inhibitor. Among other things, the data
…
Read more
0
- in Oncology
- — 15 Dec, 2007
New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

Jose Baselga
JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and
…
Read more

Tagged: podcast

Sign up for AudioMedica.com news